Literature DB >> 1717132

Functional evaluation of tumor-infiltrating mononuclear cells. Detection of endogenous interferon-gamma and tumor necrosis factor-alpha in human colorectal adenocarcinomas.

A Numata1, T Minagawa, M Asano, A Nakane, H Katoh, T Tanabe.   

Abstract

Quantitative evaluation of the levels of interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) in the extracts of tumors and their corresponding normal tissues resected from 43 patients with colorectal adenocarcinoma was done using solid-phase, sandwich radioimmunoassay. The levels of both IFN-gamma and TNF-alpha detected in the tumor tissues were higher than those in the corresponding normal colorectal tissues obtained from each patient. A significant negative correlation was observed between the level of IFN-gamma and TNF-alpha in each tumor extract. The decrease of the level of IFN-gamma in the tumor correlated with the advance of clinical stage, and the levels of IFN-gamma of the patients with distant metastases were significantly lower than those of the patients without distant metastases. However, an increase in the level of TNF-alpha correlated not only with an enlarged diameter but also with the extent of the primary tumor. Immunohistochemical staining of IFN-gamma and TNF-alpha producing cells in tumor tissues showed that IFN-gamma was mainly produced by CD4+ CD8- T-lymphocytes and TNF-alpha was mainly produced by CD11c+ cells with macrophage-like morphology. These results suggest that CD4+ T-lymphocytes that produce IFN-gamma might play an important role in the antitumor response against cancer progression in human colorectal adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717132     DOI: 10.1002/1097-0142(19911101)68:9<1937::aid-cncr2820680916>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Aspirin and risk of fatal colon cancer.

Authors:  M Odeh
Journal:  Postgrad Med J       Date:  1993-03       Impact factor: 2.401

2.  Lymphocytes infiltrating colorectal cancer have low proliferative capacity but can secrete normal levels of interferon gamma.

Authors:  W J Bateman; I Donnellan; I A Fraser; L S Wong; A G Morris
Journal:  Cancer Immunol Immunother       Date:  1995-07       Impact factor: 6.968

3.  Isotype-specific regulation of MHC class II gene expression in human monocytes by exogenous and endogenous tumor necrosis factor.

Authors:  M Jasiński; J Wieckiewicz; I Ruggiero; A Pituch-Noworolska; M Zembala
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

4.  The acute phase protein response in patients receiving subcutaneous IL-6.

Authors:  R E Banks; M A Forbes; M Storr; J Higginson; D Thompson; J Raynes; J M Illingworth; T J Perren; P J Selby; J T Whicher
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

5.  Identification of novel compounds that enhance colon cancer cell sensitivity to inflammatory apoptotic ligands.

Authors:  Avijeet S Chopra; Anton Kuratnik; Eric W Scocchera; Dennis L Wright; Charles Giardina
Journal:  Cancer Biol Ther       Date:  2013-02-01       Impact factor: 4.742

6.  The pattern of cytokine gene expression in human colorectal carcinoma.

Authors:  Anna Csiszár; Tamás Szentes; Bea Haraszti; Annamária Balázs; Gyôzô G Petrányi; Eva Pócsik
Journal:  Pathol Oncol Res       Date:  2004-06-09       Impact factor: 2.874

7.  Interactions between rnacrophage cytokines and eicosanoids in expression of antitumour activity.

Authors:  S Ben-Efraim
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

8.  TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells.

Authors:  Daniel S Straus
Journal:  Mol Cancer       Date:  2013-07-17       Impact factor: 27.401

Review 9.  Interaction of dietary fatty acids with tumour necrosis factor family cytokines during colon inflammation and cancer.

Authors:  Jiřina Hofmanová; Nicol Straková; Alena Hyršlová Vaculová; Zuzana Tylichová; Barbora Safaříková; Belma Skender; Alois Kozubík
Journal:  Mediators Inflamm       Date:  2014-04-30       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.